CAXTON ADVANTAGE LIFE SCIENCES FUND
Caxton Advantage Life Science Fund is a New York-based financial firm that invests into companies in the life-science field.
CAXTON ADVANTAGE LIFE SCIENCES FUND
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Register.com DNS Network Solutions
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-11-20 | VIVUS | Caxton Advantage Life Sciences Fund investment in Post-IPO Equity - VIVUS | 33.6 M USD |
| 2014-08-04 | Mevion Medical Systems | Caxton Advantage Life Sciences Fund investment in Private Equity Round - Mevion Medical Systems | 200 M USD |
| 2013-06-25 | Mevion Medical Systems | Caxton Advantage Life Sciences Fund investment in Private Equity Round - Mevion Medical Systems | 55 M USD |
| 2012-12-17 | Regado Biosciences | Caxton Advantage Life Sciences Fund investment in Series E - Regado Biosciences | 51 M USD |
| 2010-08-24 | Gemin X Pharmaceuticals | Caxton Advantage Life Sciences Fund investment in Series E - Gemin X Pharmaceuticals | 8 M USD |
| 2010-04-20 | Gemin X Pharmaceuticals | Caxton Advantage Life Sciences Fund investment in Series D - Gemin X Pharmaceuticals | 16 M USD |
| 2009-12-17 | Regado Biosciences | Caxton Advantage Life Sciences Fund investment in Series D - Regado Biosciences | 40 M USD |
| 2009-04-07 | Sunesis Pharmaceuticals | Caxton Advantage Life Sciences Fund investment in Post-IPO Equity - Sunesis Pharmaceuticals | 43.5 M USD |
| 2009-01-01 | Mevion Medical Systems | Caxton Advantage Life Sciences Fund investment in Venture Round - Mevion Medical Systems | 33 M USD |
| 2008-08-14 | Anthera Pharmaceuticals | Caxton Advantage Life Sciences Fund investment in Venture Round - Anthera Pharmaceuticals | 19 M USD |